Unveiling Pharmacological Mechanisms of Bombyx mori (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular Simulation Study
Pharmaceutics · 24.02.2025 · 17 (3) · 295
DOI: 10.3390/pharmaceutics17030295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.02.2025. Verfasst von Doni Dermawan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-661 Warsaw, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).
Abstract (Originalsprache)
Background
Ischemic heart disease (IHD), a leading cause of cardiovascular morbidity and mortality, continues to challenge modern medicine. Bombyx mori (Abresham), a traditional ingredient in Unani medicine, has shown promise in cardiovascular health, but its molecular mechanisms remain poorly understood.
Methods
To explore the therapeutic potential of Bombyx mori for IHD, an integrative molecular simulation approach was applied. Network pharmacology was employed to identify the most favorable target receptor for the disease. Molecular docking simulations evaluated the binding affinities of chemical and protein-based compounds from Bombyx mori to the selected receptor. Molecular dynamics (MD) simulations confirmed the stability of these interactions under physiological conditions. Pharmacophore modeling identified key structural features critical for bioactivity, while in silico toxicity assessments evaluated the safety profiles of the compounds.
Results
Key bioactive compounds from Bombyx mori, including Menaquinone-7, Quercetin, and Behenic acid, showed strong interactions with the target receptor, ACE2. The MD-based MM/PBSA calculations revealed the binding free energy values of Menaquinone-7 (−35.12 kcal/mol), Quercetin (−29.38 kcal/mol), and Behenic acid (−27.76 kcal/mol), confirming their strong binding affinity. Protein-based compounds, such as Chorion class high-cysteine HCB protein 13 (−212.43 kcal/mol), Bombyxin A-5 (−209.36 kcal/mol), and FMRFamide-related peptides (−198.93 kcal/mol), also displayed promising binding affinities. In silico toxicity assessments revealed favorable safety profiles for most compounds.
Conclusions
This study positions Bombyx mori as a promising source of therapeutic agents for IHD. Future work should focus on experimental validation of these computational findings through in vitro and in vivo studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Applied Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 00-661 Warsaw, Poland.
- Health Sciences Research Center (HSRC), Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia.
ORCID-Profile: Doni Dermawan, Nasser Alotaiq
Förderung
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)
Zitieren
APA
Dermawan, D., & Alotaiq, N. (2025). Unveiling Pharmacological Mechanisms of Bombyx mori (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular Simulation Study. Pharmaceutics, 17(3), 295. https://doi.org/10.3390/pharmaceutics17030295
Vancouver
Dermawan D, Alotaiq N. Unveiling Pharmacological Mechanisms of Bombyx mori (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular Simulation Study. Pharmaceutics. 2025;17(3):295. doi:10.3390/pharmaceutics17030295
BibTeX
@article{Dermawan2025,
author = {Dermawan, Doni and Alotaiq, Nasser},
title = {Unveiling Pharmacological Mechanisms of Bombyx mori (Abresham), a Traditional Arabic Unani Medicine for Ischemic Heart Disease: An Integrative Molecular Simulation Study},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {3},
pages = {295},
doi = {10.3390/pharmaceutics17030295}
}
EUVIMED